The Vital Role of Monoclonal Antibodies in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyposis
Allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyposis (CRSwNP) are common inflammatory conditions of the upper airways that significantly impact patients’ quality of life. Though both are distinct upper […]
Posted on
FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis
Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation of the nose and paranasal sinuses which lasts for more than 12 weeks. Signs and symptoms of sinusitis include […]
Posted on